CDA Essentials 2018 • Volume 5 • Issue 2

Week 6 Week 2 27.92 44.73 26.83 45.68 Least Squares Mean forModi ed Gingival Index PercentReduction fromBaseline toWeek2andWeek6 Philips Sonicare DiamondClean Oral-B 7000 49.38 66.75 58.76 75.81 Week 6 Week 2 Least Squares Mean forGingival Bleeding Index PercentReduction fromBaseline toWeek2andWeek6 Philips Sonicare DiamondClean Oral-B 7000 18.28 38.68 20.70 37.58 Week 6 Week 2 Least Squares Mean forModi ed Plaque Index PercentReduction fromBaseline toWeek2andWeek6 Philips Sonicare DiamondClean Oral-B 7000 Week 6 Week 2 27.92 44.73 26.83 45.68 Least Squares Mean forModi ed Gingival Index PercentReduction fromBaseline toWeek2andWeek6 Philips Sonicare DiamondClean Oral-B 7000 49.38 66.75 58.76 75.81 Week 6 Week 2 Least Squares Mean forGingival Bleeding Index PercentReduction fromBaseline toWeek2andWeek6 Philips Sonicare DiamondClean Oral-B 7000 18.28 38.68 20.70 37.58 Week 6 Week 2 Least Squares Mean forModi ed Plaque Index PercentReduction fromBaseline toWeek2andWeek6 Philips Sonicare DiamondClean Oral-B 7000 Week 6 26.83 45.68 Modi ed Gingival Index aseline toWeek2andWeek6 ondClean 49.38 66.75 58.76 75.81 Week 6 Week 2 Least Squares Mean forGingival Bleeding Index PercentReduction fromBaseline toWeek2andWeek6 Philips Sonicare DiamondClean Oral-B 7000 18.28 38.68 20.70 37.58 Week 6 Week 2 Least Squares Mean forModi ed Plaque Index PercentReduction fromBaseline toWeek2andWeek6 Philips Sonicare DiamondClean Oral-B 7000 An evidence-based approach to daily plaque control and gingival health See the latest clinical evidence from Philips Sonicare, as published in a Special Issue of The Journal of Clinical Dentistry ® Behind every Philips Sonicare product is a global team of dedicated and experienced people collaborating across a spectrum of disciplines, including research and development, product design and engineering, quality testing, clinical evaluation, manufacturing and fulfillment and distribution. With each innovation, the team’s collective efforts have an overriding goal: to provide your patients the very best tools to optimize their oral health. In order to establish a firm basis of safety and efficacy, Philips Sonicare products are repeatedly subjected to rigorous evaluation in a clinical trial setting. Four such clinical trials and one meta-analysis were recently published in a Special Issue of The Journal of Clinical Dentistry ® . Following are highlights from these studies. Complete details are available at philips.com/clinical . *Brush head formally called AdaptiveClean ©2018 Koninklijke Philips N.V. All rights reserved. Specifications can be changed without prior notice. Trade names belong to Koninklijke Philips N.V. or their respective owners. This article is sponsored content from Philips Philips Sonicare DiamondClean vs. Oral-B 7000® Starke M, Delaurenti M, Ward M, Souza S, Milleman KR, Milleman JL. J Clin Dent 2017;28(Spec Iss A):A29-35. Salus Research, Ft. Wayne IN, USA 284 subjects Randomized, parallel, single-blind Key conclusions: Philips Sonicare DiamondClean with Premium plaque control * brush head was statistically superior to Oral-B 7000® with CrossAction™ brush head in reducing gingival inflammation, as measured by MGI; reducing gingival bleeding, as measured by GBI; and reducing surface plaque, as measured by MPI, following 14 and 42 days of home use. Results - Percent reduction at Week 4 25.5% 57.4% 34.9% 19.1% 31.4% 8.0% Gingivitis Bleeding Plaque Sonicare MTB 284 week 2 >> 4 Earning the trust of dental professionals, one innovation at a time